Tecentriq®
Immunotherapy Shows Promise for TNBC Patients
May 13, 2019 at 04:25 pm by Staff
FDA Approves Tecentriq® as First Immunotherapy Regimen for Breast Cancer
A breakthrough therapy is offering unprecedented hope to women with metastatic triple negative breast.... Read More